Chapter
1.3 Special Aspects of Forensic Toxicology (H. Brandenberger)
pp.：
59 – 71
1.4 Analytical Aspects of Doping in Sports (D. de Boer, T. J. A. Seppenwoolde-Waasdorp and R. A. A. Maes)
pp.：
71 – 101
1.5 Pharmacokinetics as Applied to Drug and Doping Research (T. B. Vree)
pp.：
101 – 115
1.6 The Future of Immunochemical Drug Analysis (T. Takatori and M. Nagao)
pp.：
115 – 127
1.7 The Future of Instrumental Analysis in Toxicology (H. Brandenberger)
pp.：
127 – 147
Part 2 Chapters Concerned with Special Poison Classes
pp.：
147 – 149
2.1 Natural Gases and Vapors (H. Brandenberger)
pp.：
149 – 161
2.2 Carbon Monoxide (T. Kojima)
pp.：
161 – 169
2.3 Determination of Alcohol Levels in the Body (H. Brandenberger, R. Brandenberger and K. Halder)
pp.：
169 – 205
2.4 Volatile Hydrocarbons (T. Nagata and K. Kimura)
pp.：
205 – 215
2.5 Volatile Halogenated Compounds (R. J. Flanagan)
pp.：
215 – 243
2.6 Pesticides (M. Geldmacher-v. Mallinckrodt and G. Machbert)
pp.：
243 – 293
2.7 Glycols (M. Roth)
pp.：
293 – 297
2.8 Inorganic Anions (M. Roth)
pp.：
297 – 309
2.9 Non-Metals of Group 16 (M. Roth and M. Pelletier)
pp.：
309 – 313
2.10 Metals of Toxicological Significance (H. Brandenberger and M. Roth)
pp.：
313 – 373
3.3 Hypnotics and Sedatives Not Belonging to the Classes of Barbiturates and Benzodiazepines (H. Brandenberger)
pp.：
367 – 455
Part 3 Toxicological Drug Analysis
pp.：
373 – 375
3.1 Barbiturates (H. Brandenberger)
pp.：
375 – 397
3.2 Benzodiazepines (H. Schütz)
pp.：
397 – 367
3.4 Anticonvulsants Not Belonging to the Classes of Barbiturates and Benzodiazepines (W. R. Külpmann)
pp.：
455 – 479
3.5 Neuroleptics (R. Whelpton)
pp.：
479 – 509
3.6 Antidepressants (R. A. Braithwaite)
pp.：
509 – 523
3.7 Beta-Blocking Drugs (M. S. Leloux)
pp.：
523 – 537
3.8 Analgesics, Antipyretics and Non-Steroidal Anti-Inflammatory Agents (B. Widdop)
pp.：
537 – 571
3.9 Antihistamines (H. Brandenberger)
pp.：
571 – 591
3.10 Volatiles Used and Abused as Anesthetics (H. Brandenberger)
pp.：
591 – 607
3.11 Digitalis (= Cardiac) Glycosides (J. Hallbach and H. Vogel)
pp.：
607 – 625
3.12 Cyclosporins (D. W. Holt)
pp.：
625 – 637
3.13 Anticoagulants (M. Geldmacher-v. Mallinckrodt)
pp.：
637 – 649
3.14 Alkaloids (Y. Kuroiwa and T. Yoshida)
pp.：
649 – 691
3.15 Stimulants (D. de Boer, T. J. A. Seppenwoolde-Waasdorp and R. A. A. Maes)
pp.：
691 – 713
3.16 Designer Drugs (G. L. Henderson)
pp.：
713 – 733
Part 4 Blood Level Data
pp.：
733 – 735
4.1 Blood Level Data (D. R. A. Uges)
pp.：
735 – 747
Analytical Toxicology for Clinical, Forensic and Pharmaceutical Chemists
( Clinical Biochemistry )
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
